Literature DB >> 11419167

MR imaging of clear cell carcinoma of the ovary.

Y Matsuoka1, K Ohtomo, T Araki, K Kojima, W Yoshikawa, S Fuwa.   

Abstract

Magnetic resonance imaging findings are reported for 12 pathologically proven lesions of clear cell carcinoma (CCC) of the ovary in 11 women (mean age 50 years). T1- and T2-weighted MR images were obtained in all patients, and gadolinium-enhanced MR images were obtained in 9. The mean diameter of the tumors was 13 cm. Seven patients presented with stage-I tumors. All 12 lesions consisted of cystic masses with solid protrusions occurring in 10 and solid masses in 2. The cysts were unilocular in 9 lesions and multilocular in 1. In four lesions, the cysts displayed with high intensity on T1-weighted images. Round solid protrusions were identified in 8 lesions. In 5 lesions, the number of protrusions was only a few. The solid portions of 5 masses had slightly high-intensity regions on T1-weighted images. The number of patients with ascites was three. Magnetic resonance imaging of CCC usually shows a unilocular large cyst with solid protrusions, which are often round and few in number. Such MR imaging findings suggest malignant tumor but are not specific.

Entities:  

Mesh:

Year:  2001        PMID: 11419167     DOI: 10.1007/s003300000671

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  10 in total

1.  Synchronous primary tumors of the kidney and the ovaries: Imaging findings.

Authors:  Athina C Tsili; Areti Charisiadi; George Koliopoulos; Sevasti Kamina; Michalis Doukas; Evagellos Paraskevaidis; Konstantine Tsampoulas
Journal:  J Radiol Case Rep       Date:  2008-11-01

2.  Multimodality imaging of ovarian cystic lesions: Review with an imaging based algorithmic approach.

Authors:  Ashish P Wasnik; Christine O Menias; Joel F Platt; Usha R Lalchandani; Deepak G Bedi; Khaled M Elsayes
Journal:  World J Radiol       Date:  2013-03-28

3.  Magnetic resonance imaging findings of endometrioid adenocarcinoma of the ovary.

Authors:  Kazuhiro Kitajima; Yasushi Kaji; Yoichiro Kuwata; Kazufumi Imanaka; Ryo Sugihara; Kazuro Sugimura
Journal:  Radiat Med       Date:  2007-08-27

4.  MR features of fluid-fluid levels in ovarian masses.

Authors:  Eun-Ah Park; Jeong Yeon Cho; Min Woo Lee; Sun Ho Kim; Chang Kyu Seong; Seung Hyup Kim
Journal:  Eur Radiol       Date:  2007-07-17       Impact factor: 5.315

5.  Clear cell carcinoma of the ovary: multi-slice computed tomography findings.

Authors:  Xubin Li; Zhaoxiang Ye
Journal:  World J Surg Oncol       Date:  2015-04-01       Impact factor: 2.754

6.  Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma.

Authors:  Wei Wang; Jianhui Ding; Xiaoli Zhu; Yuan Li; Yajia Gu; Weijun Peng
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

Review 7.  Non-neoplastic diseases of the fallopian tube: MR imaging with emphasis on diffusion-weighted imaging.

Authors:  Pietro Valerio Foti; Noemi Ognibene; Saveria Spadola; Rosario Caltabiano; Renato Farina; Stefano Palmucci; Pietro Milone; Giovanni Carlo Ettorre
Journal:  Insights Imaging       Date:  2016-03-18

8.  Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.

Authors:  Feng-Hua Ma; Jin-Wei Qiang; Guo-Fu Zhang; Hai-Ming Li; Song-Qi Cai; Ya-Min Rao
Journal:  J Ovarian Res       Date:  2016-07-04       Impact factor: 4.234

9.  MR imaging of ovarian masses: classification and differential diagnosis.

Authors:  Pietro Valerio Foti; Giancarlo Attinà; Saveria Spadola; Rosario Caltabiano; Renato Farina; Stefano Palmucci; Giuseppe Zarbo; Rosario Zarbo; Maria D'Arrigo; Pietro Milone; Giovanni Carlo Ettorre
Journal:  Insights Imaging       Date:  2015-12-16

10.  Malignant Transformation of an Ovarian Endometrioma during Endometriosis Treatment: A Case Report.

Authors:  Hiroaki Takagi; Emi Takata; Jinichi Sakamoto; Satoko Fujita; Masahiro Takakura; Toshiyuki Sasagawa
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.